Background. Very few cases of non-organized and non-Randall-type monoclonal immunoglobulin deposition disease (MIDD) associated with membranous features have been reported. Information on clinicopathological features and prognosis in this entity is limited. Methods. We reviewed 5443 renal biopsies processed at our department, and identified three patients with MIDD associated with membranous features. We evaluated clinicopathological features and outcomes in these patients. Results. All patients had proteinuria, and one patient developed nephrotic syndrome. Renal insufficiency was not observed. Cryoglobulin or monoclonal protein in serum and urine was not detected. A renal biopsy showed thickening of the glomerular capillary walls and spike formation. Tubulointerstitial and vascular alterations were mild or absent. Immunofluorescence studies revealed granular IgG3-κ deposits in two patients and IgG1-κ deposits in one patient, along the glomerular capillary walls. Immunofluorescence studies using antibodies specific for γ-heavy chain Fab containing C H 1 domain, C H 2 domain and C H 3 domain did not show any apparent deletion. On confocal microscopy, glomerular colocalization of light and heavy chains was observed. Electron microscopy showed predominant subepithelial granular deposits without distinct ultrastructural organization. All patients were treated with steroids, and good effects were observed. A follow-up renal biopsy performed in one patient showed histological improvements. No patient developed myeloma or other haematological malignancy during the course of follow-up (mean 44 months). Conclusions. MIDD associated with membranous features is an extremely rare but distinctive entity. Our study suggests glomerular deposition of a nondeleted whole immunoglobulin molecule. Patients with this entity appear to respond well to steroid therapy.
Introduction
Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adults. The main pathological feature on electron microscopy is the presence of subepithelial electron-dense deposits. The characteristic immunofluorescence finding is granular staining for polyclonal immunoglobulins and complements along the glomerular basement membranes [1] .
Very few cases of non-organized and non-Randall-type monoclonal immunoglobulin deposition disease (MIDD) associated with membranous features or similar cases have been reported in the literature [2] [3] [4] [5] . Ultrastructural glomerular lesion in Randall-type MIDD is characterized by continuous linear deposits of finely granular electrondense material along the inner aspect of the glomerular basement membranes [6] . Four cases of glomerulopathy with IgG-κ or IgG-λ deposits were reported by Bridoux et al. in 2001. In their series of patients, granular parietal deposits without distinct ultrastructural organization were predominantly membranous [2] . One of these patients was described in detail by Touchard in 2003 [3] . They proposed the term non-organized and non-Randall-type MIDD to individualize this rare entity. A similar case was also described by Evans et al. [4] in 2003. Nasr et al. [5] reported 10 cases of proliferative glomerulonephritis (GN) with monoclonal IgG deposits in 2004. In their series of patients, one patient had membranous features on light microscopy. The single case with membranous features in Nasr's series [5] had IgG1-κ deposits. In this case, the postbiopsy follow-up time was limited to 2 months. Information on clinicopathological features and prognosis in non-organized and non-Randall-type MIDD associated with membranous features or proliferative GN associated with membranous features is presently limited.
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In the present study, we reviewed 5443 renal biopsies processed at our department, and identified three patients with MIDD associated with membranous features. Two patients had IgG3-κ deposits and one patient had IgG1-κ deposits. These deposits were not organized and not of Randall type on electron microscopy. We evaluated clinicopathological features and outcomes in these patients. We also characterized these paraprotein deposits by immunofluorescence studies.
Subjects and methods

Patients
This study was based on the renal histological records of 5443 patients studied at Akita University Hospital and its affiliated hospitals. Glomerular stainings for light and heavy chains were evaluated in 4864 patients by immunofluorescence studies. MIDD associated with membranous features was defined by the modified criteria for proliferative GN with monoclonal IgG deposits [5] : (1) the presence of glomerular monoclonal IgG deposits restricted to a single IgG subclass and a single light chain isotype, associated with membranous features without proliferative patterns; (2) the presence of granular ('immune complex type') deposits by electron microscopy and (3) the absence of clinical and laboratory evidence of cryoglobulinaemia. There were three patients with MIDD associated with membranous features. There were four patients with proliferative GN with monoclonal IgG deposits associated with membranoproliferative features.
Clinical and laboratory information was obtained on each patient at the time of renal biopsy. Follow-up information was obtained in all patients. Hypertension was defined as systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg, or the use of antihypertensive medications at the time of biopsy. Nephrotic syndrome was defined as urinary protein ≥3.5 g/day, hypoalbuminaemia (serum albumin ≤3.0 g/dl) and oedema. Renal insufficiency was defined as serum creatinine ≥1.2 mg/dl. Positive serum protein and urine protein immunoelectrophoresis were defined by the presence of monoclonal bow.
A follow-up renal biopsy was performed in one patient (patient 1) after 4-year treatment.
Pathological studies
The renal biopsy specimens were processed using standard techniques for light, immunofluorescence and electron microscopy. Determination of the IgG subclass was performed on cryostat sections. Sections were stained with mouse monoclonal antibodies to human IgG1 (clone 8c/6-39), IgG2 (clone HP6014), IgG3 (clone HP6050) and IgG4 (clone HP6025) (The Binding Site, Birmingham, UK), followed by fluorescein isothiocyanate (FITC)-conjugated anti-mouse IgG (Cappel, Aurora, OH, USA). Renal biopsy specimens from all patients were further examined with monoclonal antibodies specific for human γ-heavy chain Fab containing C H 1 domain, C H 2 domain and C H 3 domain. Cryostat sections from patients were stained with mouse 
Results
Clinical features
Clinical features in our three patients with MIDD associated with membranous features are summarized in Table 1 . All patients were males. The median age was 37 years (range 24-44). At presentation, no patient had hypertension and one patient had oedema. There were no symptoms or signs of multiple myeloma or cryoglobulinaemia in all patients. All patients had proteinuria, and one patient developed nephrotic syndrome. Microscopic haematuria was present in one patient. Renal insufficiency (serum creatinine ≥1.2 mg/dl) was not present in any patient. Leukocytosis was found in two patients, but anaemia or thrombocytopenia was not observed in any patient. Serum levels of calcium, IgA and IgM were normal in all patients, but serum IgG levels decreased in two patients. Hypocomplementaemia was found in one patient. Serological workup showed no anti-nuclear antibody or cryoglobulin in any patient. By serum and urine protein immunoelectrophoresis, monoclonal protein in blood or Bence-Jones protein was not detected in any patient. Other studies for the detection of monoclonal proteins, such as immunoblotting, and bone marrow examinations were not performed in any patient.
All patients were treated with steroids alone, and none of them received angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists. Patient 1 was treated with methylprednisolone pulse therapy (500 mg/ day) for 3 days followed by oral prednisolone therapy (30 mg/day) for 4 weeks. Thereafter, prednisolone was tapered gradually. Patients 2 and 3 were treated with oral prednisolone therapy (40 mg/day for 4 weeks and 30 mg/day for 8 weeks, respectively). Thereafter, prednisolone was tapered gradually. Good effects on proteinuria were observed in all patients. Renal function was reserved in all patients. No patient developed myeloma or other haematological malignancy, during the course of follow-up (mean 44 months).
Pathological features
Pathological features in our three patients with MIDD associated with membranous features are summarized in Table 2 . Renal histological findings in a representative case (patient 3) are shown in Figures 1 and 2 . Light microscopy showed thickening of the glomerular capillary walls and spike formation without proliferative patterns such as endocapillary and mesangial proliferation. Homogenous giant deposits were observed in two patients. Tubulointerstitial and vascular alterations were mild or absent in all patients. Congo red staining for amyloid was negative in all patients. Immunofluorescence studies revealed glomerular IgG-κ deposits in all patients. Staining for λ-light chain was negative in all cases. The deposits stained only for a single IgG subclass: IgG3 (with negative IgG1, IgG2 or IgG4) in two patients and IgG1 (with negative IgG2-4) in one patient. There was no granular peripheral capillary wall staining for IgA or IgM in all patients. Glomerular C3 and C1q deposits were also found in three and two patients, respectively. Significant deposition along the tubular basement membranes was not observed in any patient. By electron microscopy, non-organized and non-Randall-type granular electron-dense deposits were identified in the subepithelial space of the glomerular basement membranes in one patient. Predominant subepithelial deposits with subendothe- 
GBM, glomerular basement membrane; TBM, tubular basement membrane.
lial and mesangial deposits were observed in two patients ( Figure 2 ). Biopsy specimens from all patients were also stained with antibodies specific for γ-heavy chain Fab containing C H 1 domain, C H 2 domain and C H 3 domain. The results did not show any apparent deletion. Dual immunostaining of biopsy specimens from all patients disclosed colocalization of γ1or γ3-heavy chain and κ-light chain along the glomerular capillary walls (Figure 3) .
A follow-up renal biopsy performed in one patient after 4-year treatment showed remarkable histological improvements of thickening of the glomerular capillary walls and spike formation (Figure 4 ).
Discussion
In the present study, we reviewed 5443 renal biopsies, and identified three patients with MIDD associated with membranous features. Glomerular deposits were not organized and not of Randall type in these patients. This novel form of glomerulopathy is an extremely rare entity (biopsy incidence 0.055%).
Very few cases of non-organized and non-Randalltype MIDD associated with membranous features or similar cases have been reported in the literature [2] [3] [4] [5] . Bridoux et al. [2] reported four cases of glomerulopathy with IgG-κ or IgG-λ deposits (2 IgG3-κ, 1 IgG2-κ, and 1 IgG3-λ). In their patients, granular parietal deposits were predominantly membranous. Touchard [3] described one of these patients in detail, a 48-year-old man. This patient developed hypertension and nephrotic syndrome with renal insufficiency. A renal biopsy showed thickened glomerular capillary walls with IgG3-λ and complement deposits. Serum immunoelectrophoresis detected no Immunofluorescence microscopy for IgG-heavy chain (C), γ3-heavy chain (D), κ-light chain (E) and λ-light chain (F) displays strong staining for IgG-heavy chain, γ3-heavy chain and κ-light chain along the glomerular capillary walls with a granular texture, but no significant staining for λ-light chain (original magnification ×400). monoclonal component. However, immunoblotting revealed the presence of monoclonal IgG3-λ. After six courses of melphalan and prednisolone, remission of the nephrotic syndrome was obtained. Renal insufficiency also improved. Evans et al. [4] reported an 81-year-old woman with follicular B-cell lymphoma who developed nephrotic syndrome. Bence-Jones protein (κ-chain) was detected. This patient died from pulmonary thromboembolism 7 weeks after the start of chemotherapy. Postmortem histological examination of the kidneys and elution studies revealed subepithelial granular IgG1-κ deposits. There was no evidence of cryoprecipitability of the monoclonal protein. A 63-year-old woman in Nasr's series [5] had proliferative GN with IgG1-κ deposits associated with membranous features. The total urinary protein for 24 h was 2g, serum albumin was 2.7 g/dl and serum creatinine was 0.9 mg/dl. IgG-κ paraprotein was detected in serum and urine. This patient was treated with an angiotensin-converting in-hibitor, but the postbiopsy follow-up time was limited to 2 months.
All our three patients with MIDD associated with membranous features had proteinuria, and one patient developed nephrotic syndrome. Renal insufficiency was not observed. In our patients, monoclonal protein was not detected in serum and urine. The inability to identify a corresponding monoclonal protein may relate to its presence at very low titers, below the level of detection by standard immunoelectrophoresis, or to rapid rates of tissue deposition [5] . All our patients responded well to steroid therapy. A follow-up renal biopsy performed in one patient after 4-year treatment showed remarkable histological improvements. No patient developed myeloma or other haematological malignancy during the course of follow-up (mean 44 months). Longer follow-up is needed to determine implications for the possible development of haematological malignancy. Hypocomplementaemia was present in one of our three patients with MIDD associated with membranous features. This patient had IgG1 deposits. Glomerular C3 and C1q deposits were also observed. This may result from the high complement fixation ability of γ1-heavy chain [7] . The mechanism of hypocomplementaemia in our patient presumably involves comple-ment consumption through activation on γ1-heavy chain deposits.
Previously reported cases of non-organized and non-Randall-type MIDD associated with membranous features [2] and our cases had IgG1-κ, IgG2-κ, IgG3-κ or IgG3-λ deposits. This suggests that patterns of IgG subclass deposits in MIDD associated with membranous features are different from those in idiopathic MN characterized by a predominant IgG4 deposition [8] . Our immunofluorescence studies showed colocalization of γ1or γ3-heavy chain and κ-light chain along the glomerular capillary walls and no apparent deletion in γ-heavy chain C H 1 domain, C H 2 domain and C H 3 domains in all patients. This suggests paraprotein of deposits of a nondeleted whole immunoglobulin molecule. The single case of proliferative GN with monoclonal IgG deposits associated with membranous features in Nasr's series [5] also stained for γ-heavy chain C H 1 domain, C H 2 domain and C H 3 domains. In contrast, a deletion of C H 1 domain was found in most patients with heavy chain deposition disease (HCDD), another form of glomerulopathy associated with monoclonal IgG deposits [9] . Light microscopic, immunofluorescence, and electron microscopic features in MIDD associated with membranous features are also different from those in HCDD, which is characterized by nodular sclerosing glomerulopathy and detectable paraprotein deposits within basement membranes throughout the kidney [10] .
In conclusion, MIDD associated with membranous features is an extremely rare but distinctive entity. Our immunofluorescence studies suggest paraprotein deposits of a nondeleted whole immunoglobulin molecule. Patients with this entity appear to respond well to steroid therapy. The accumulation of cases is needed for further determination of its clinicopathological features and outcome.
